Revenue Cycle Management Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Revenue Cycle Management Market

Revenue Cycle Management Market Size by Product & Services (Eligibility Verification, Clinical Coding, CDI Solutions, Claims Processing, Denial Management, Outsourcing Services), Delivery (Cloud), End Users (Payers, Hospitals) & Region - Global Forecast to 2028

FREE BROCHURE FREE SAMPLE REPORT
Report Code: HIT 4017 Jun, 2023, by marketsandmarkets.com

The size of global revenue cycle management market in terms of revenue was estimated to be worth $49.6 billion in 2023 and is poised to reach $84.1 billion by 2028, growing at a CAGR of 11.1% from 2023 to 2028. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Adoption of RCM solutions has increased post the pandemic to reduce the burden on healthcare resources. Newly developed RCM solutions help streamline workflows, enhance data accuracy, improve compliance, and provide a better overall experience for healthcare providers and patients. Furthermore, these RCM solutions offer real-time insights, enable seamless data exchange, support interoperability, and reduce costs for managing multiple standalone systems. Therefore, the rising availability of highly efficient RCM solutions has positively influenced market growth. Moreover, improving data integration standards such as HL7 for efficient data transfer has further enhanced the RCM market growth.

Revenue Cycle Management Market

To know about the assumptions considered for the study, Request for Free Sample Report

Revenue Cycle Management Market

Revenue cycle management Market Dynamics

Driver: Growing need to manage unstructured healthcare data

In the last few years, the volume of electronic data produced in the healthcare industry, primarily due to rising patient volumes and the digitization of administrative, clinical, and financial information, has expanded to terabytes and petabytes. This generates an imperative need to use revenue cycle management solutions. According to industry experts, by using natural language processing (NLP) and optical character recognition (OCR) technology, organizations can transform unstructured data from files, such as medical records, scanned documents, and audio recordings, into structured and normalized data. Other significant factors contributing to this trend are the sheer diversity of data in healthcare and the rising prominence and usage of HCIT tools.

Restraint: Deployment costs include licensing and subscription costs, hardware infrastructure, customization costs, and implementation services cost.

Cost of licensing and implementation is substantially high. Moreover, the price associated with maintaining revenue cycle management software has also significantly increased. Furthermore, IT support and maintenance services, including modifying and upgrading software per changing user requirements and maintaining an efficient IT infrastructure, represent a recurring expenditure. This accounts for a large share of the total cost of ownership. Also, post-sale custom interface development for device integration requires additional verification and validation to ensure solution accuracy and completeness. In 2021, many healthcare providers and their revenue cycle management (RCM) departments faced challenges. Operational costs outpaced revenue growth leading to months and quarters in the red. At the end of 2022, the American Hospital Association anticipated that between 53% and 68% of hospitals would be in deficit, compared to 34% in 2019. This further increases the total cost of ownership for healthcare providers. As a result of the high costs involved, small healthcare facilities, especially in emerging countries, are reluctant to replace their legacy systems with RCM solutions.

Opportunity: Growing demand for AI & cloud-based deployment

The combination of data and artificial intelligence (AI) has the potential to improve outcomes and reduce costs by applying machine learning algorithms and predictive analytics to reduce drug discovery times, provide virtual assistance to patients, and reduce the diagnosing time for ailments by processing medical images. The adoption of AI in healthcare is rising due to its ability to optimize clinical as well as non-clinical processes, thereby solving a variety of problems for patients, providers, and the overall healthcare industry. According to MarketsandMarkets estimates, AI in Healthcare market is predicted to grow at a double-digit rate. AI has experienced high demand for RCM solutions to overcome the load on human resources. Manual and redundant tasks that occur during patient access, coding, billing, collections, and denials can be automated with the help of AI. AI integrated with RCM can perform these functions more accurately by imitating intelligent human behavior through algorithms that find patterns and plan future actions to produce a positive outcome.

Challenge: Issues related to data security and confidentiality

The increased use of automated technologies such as EHRs, healthcare integration, and health information exchanges have helped expand the healthcare privacy and security landscape. Electronic patient data exchange offers greater reach and efficiency in healthcare delivery but has high-security risks due to the broader access. The Anthem Inc. Data breach, Ransomware attack, and Accellion FTA Hack have been the most significant cyberattacks in recent years, jeopardizing USD 47.76 million patient records altogether, causing USD 81.5 million loss. Concerns over the security of proprietary data and applications form a significant challenge to the growth of the market.

Revenue Cycle Management Market Ecosystem

The aspects present in this market are included in the ecosystem market map of the overall revenue cycle management market, and each element is defined with a list of the organizations involved. Products and services are included.  The manufacturers of various products include the organizations involved in the entire process of research, product development, optimization, and launch. Vendors provide the services to end users either directly or through a collaboration with a third party.

In-house research facilities, contract research organizations, and contract development and manufacturing companies are all part of research and product development and are essential for outsourcing product development services.

Revenue Cycle Management Market Ecosystem

Source: Secondary Literature, Interviews with Experts, and MarketsandMarkets Analysis

By product & services segment, the outsourcing services segment of revenue cycle management industry is expected to grow at the highest growth rate during the forecast period

The outsourcing services segment of revenue cycle management market is expected to grow at the highest CAGR during the forecast period among the product & services. RCM services are outsourced to improve financial performance, navigate complex regulatory landscapes, access specialized expertise, leverage advanced technology, and focus on core healthcare operations. Outsourcing RCM allows organizations to optimize revenue cycles, enhance financial outcomes, and streamline processes in a rapidly changing healthcare environment. Therefore, due to the above-mentioned benefits, the segment is predicted to have a significant growth rate.

The on-premise segment is expected to account for the largest revenue cycle management industry share by delivery mode.

The on-premise segment accounted for the largest share of the revenue cycle management market in 2022. On-premise RCM software provides organizations with greater customization and flexibility. Since the software is deployed locally, it can be tailored to specific workflows, processes, and reporting requirements. This allows organizations to align the RCM software more closely with their unique needs, providing a more personalized and efficient solution thereby, elevating the segment share.

By end user, the healthcare providers segment is expected to account for the largest revenue cycle management industry share.

Healthcare payers and providers are the two segments of the global revenue cycle management market based on end users. The healthcare providers segment accounted for the largest market share 2022. The significant market share of this sector can be ascribed to the effective RCM processes and technologies that provide healthcare providers with improved financial performance, streamlined workflows, enhanced compliance, and a better overall patient experience. By leveraging RCM solutions, healthcare organizations can optimize revenue cycles, increase efficiency, and allocate resources more effectively to deliver high-quality patient care. The aforementioned factors have positively impacted segmental growth.

Revenue Cycle Management Market by Region

To know about the assumptions considered for the study, download the pdf brochure

During the forecast period, the Asia Pacific region had a substantial growth rate in the revenue cycle management market. The regional growth can be attributed to the rising penetration of digital healthcare technologies along with improving infrastructure. Moreover, medical tourism is increasing especially in the South East Countries that has further elevated the regional market growth to a certain extent.

The major players in the global revenue cycle management market are R1 RCM (US), Oracle (US), Optum (US). Other prominent players in the market include AdvantEdge Healthcare (US), McKesson Corporation (US), Change Healthcare (US), 3M (US), Experian plc (Ireland), Conifer Health Solutions (US), Veradigm (US), GE Healthcare (US), Cognizant (US), athenahealth (US), SSI Group LLC (US), McKesson Corporation (US), and Huron Consulting Group (US).

Scope of the Revenue Cycle Management Industry

Report Metric

Details

Market Revenue Size in 2023

$49.6 billion

Projected Revenue Size by 2028

$84.1 billion

Industry Growth Rate

Poised to Grow at a CAGR of 11.1%

Market Driver

Technological advancements and increasing R&D investments

Market Opportunity

Improvisation of healthcare infrastructure across emerging countries

The research report categorizes the revenue cycle management market to forecast revenue and analyze trends in each of the following submarkets:

By Product & Services
  • Solutions
    • Patient Access Solutions
      • Eligibility Verification Solutions
      • Pre-certification & Authorization Solutions
      • Other Patient Access Solutions
    • Mid-Revenue cycle Solutions
      • Clinical Coding Solutions
      • Clinical Documentation Improvement Solutions
      • Other Mid-revenue cycle Solutions
    • Back-end Revenue cycle Solutions
      • Claims Processing Solutions
      • Denial Management Solutions
      • Other Back-end Revenue cycle Solutions
    • Outsourcing Services
      • Patient Access Outsourcing Services
      • Mid-revenue cycle Outsourcing Services
      • Back-end Revenue cycle Outsourcing Services
By Delivery Mode
  • On-premise Solutions
  • Cloud-based Solutions
By End User
  • Healthcare Providers
    • Inpatient Facilities
      • Hospitals
      • Others
    • Outpatient Facilities
      • Physicians Practices
      • Ambulatory Surgical Centers (ASCs)
      • Hospital Outpatient Facilities
      • Diagnostic & Imaging Centers
      • Other Outpatient Facilities
  • Healthcare Payers
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East and Africa

Recent Developments of Revenue Cycle Management Industry

  • In 2023, Optum partnered with Owensboro Health to manage revenue cycle and information technology and improve patient outcomes and safety.
  • In 2022, the R1 RCM announced 10-year end-to-end RCM partnerships with Scion Health, Sutter Health, and St. Clair Health to streamline workflow standardization and improve patient access platforms.
  • In 2022, McKesson signed a definitive agreement to acquire Rx Savings Solutions to offer  medication therapy more affordable and increase medication adherence to improve outcomes.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 39)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 MARKET SCOPE 
           1.3.1 INCLUSIONS AND EXCLUSIONS
           1.3.2 MARKETS COVERED
           1.3.3 REGIONS COVERED
           1.3.4 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 STAKEHOLDERS 
    1.6 LIMITATIONS 
    1.7 SUMMARY OF CHANGES 
    1.8 IMPACT OF RECESSION 
 
2 RESEARCH METHODOLOGY (Page No. - 44)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Insights from primary experts
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION: REVENUE CYCLE MANAGEMENT MARKET 
          FIGURE 4 MARKET SIZE ESTIMATION
          FIGURE 5 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          FIGURE 6 CAGR PROJECTIONS: OVERALL REVENUE CYCLE MANAGEMENT INDUSTRY
           2.2.1 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET RANKING ANALYSIS 
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT: MARKET
    2.7 RESEARCH LIMITATIONS 
           2.7.1 METHODOLOGY-RELATED LIMITATIONS
           2.7.2 SCOPE-RELATED LIMITATIONS
    2.8 IMPACT OF RECESSION ON MARKET 
 
3 EXECUTIVE SUMMARY (Page No. - 58)
    FIGURE 8 REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE,  2023 VS. 2028 (USD MILLION)
    FIGURE 9 REVENUE CYCLE MANAGEMENT INDUSTRY, BY DELIVERY MODE,  2023 VS. 2028 (USD MILLION)
    FIGURE 10 MARKET, BY END USER,  2023 VS. 2028 (USD MILLION)
    FIGURE 11 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
 
4 PREMIUM INSIGHTS (Page No. - 61)
    4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MARKET 
          FIGURE 12 GROWING REGULATORY REQUIREMENTS AND GOVERNMENT INITIATIVES  TO DRIVE MARKET
    4.2 REVENUE CYCLE MANAGEMENT INDUSTRY: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 13 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.3 REGIONAL MIX: MARKET  (2021–2028) 
          FIGURE 14 MIDDLE EAST & AFRICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 MARKET: DEVELOPED VS. EMERGING ECONOMIES, 2023 VS. 2028 (USD MILLION) 
          FIGURE 15 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 64)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          TABLE 2 REVENUE CYCLE MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing regulatory requirements and government initiatives
                    5.2.1.2 Increasing patient volume and subsequent growth in health insurance
                    5.2.1.3 Loss of revenue due to billing errors and declining reimbursements
                    5.2.1.4 Growing need to manage unstructured healthcare data
                    5.2.1.5 Rising demand for robust process improvements in healthcare sector
           5.2.2 RESTRAINTS
                    5.2.2.1 High deployment costs
                    5.2.2.2 IT infrastructural constraints in emerging economies
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing outsourcing services in emerging economies
                    5.2.3.2 Growing demand for AI and cloud-based deployment
           5.2.4 CHALLENGES
                    5.2.4.1 Issues related to data security and confidentiality
                    5.2.4.2 Reluctance to switch from conventional methods
 
6 INDUSTRY TRENDS (Page No. - 72)
    6.1 GREATER FOCUS ON PATIENT FINANCIAL EXPERIENCE 
    6.2 USE OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING 
    6.3 PIVOTAL ROLE OF DATA ANALYSIS IN MANAGING HEALTHCARE REVENUE CYCLES 
    6.4 INCREASING NUMBER OF PARTNERSHIPS AND COLLABORATIONS TO DRIVE INNOVATION 
           6.4.1 TECHNOLOGY ANALYSIS
    6.5 PORTER’S FIVE FORCES ANALYSIS 
          FIGURE 16 REVENUE CYCLE MANAGEMENT INDUSTRY: PORTER’S FIVE FORCES ANALYSIS
          TABLE 3 MARKET: PORTER’S FIVE FORCES ANALYSIS
           6.5.1 INTENSITY OF COMPETITIVE RIVALRY
           6.5.2 BARGAINING POWER OF SUPPLIERS
           6.5.3 BARGAINING POWER OF BUYERS
           6.5.4 THREAT OF NEW ENTRANTS
           6.5.5 THREAT OF SUBSTITUTES
    6.6 REGULATORY LANDSCAPE 
           6.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 7 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,  AND OTHER ORGANIZATIONS
                    TABLE 8 MARKET: REGULATORY STANDARDS
    6.7 VALUE CHAIN ANALYSIS 
          FIGURE 17 VALUE CHAIN ANALYSIS (2022)
    6.8 ECOSYSTEM/MARKET MAP 
          FIGURE 18 MARKET: ECOSYSTEM
    6.9 PATENT ANALYSIS 
          FIGURE 19 NUMBER OF PATENTS PUBLISHED, JANUARY 2013 TO JUNE 2023
          FIGURE 20 TOP REVENUE CYCLE MANAGEMENT PATENT OWNERS
          TABLE 9 KEY PATENTS IN MARKET (2020–2023)
    6.10 ADJACENT MARKET ANALYSIS 
          FIGURE 21 POPULATION HEALTH MANAGEMENT MARKET: MARKET OVERVIEW
          FIGURE 22 HEALTHCARE ANALYTICS MARKET: MARKET OVERVIEW
              6.11 CASE STUDY ANALYSIS 
    6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 
           6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
                     TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
           6.12.2 BUYING CRITERIA
                     FIGURE 24 KEY BUYING CRITERIA FOR REVENUE CYCLE MANAGEMENT COMPONENTS
                              TABLE 11 KEY BUYING CRITERIA FOR REVENUE CYCLE MANAGEMENT COMPONENTS
    6.13 KEY CONFERENCES AND EVENTS IN 2023–2024 
           TABLE 12 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    6.14 PRICING ANALYSIS 
    6.15 TRENDS/DISRUPTIONS IMPACTING BUYERS 
           FIGURE 25 MARKET: TRENDS/DISRUPTIONS IMPACTING BUYERS
 
7 REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE (Page No. - 90)
    7.1 INTRODUCTION 
          TABLE 13 REVENUE CYCLE MANAGEMENT INDUSTRY, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
    7.2 SOLUTIONS 
          TABLE 14 SOLUTIONS OFFERED BY KEY MARKET PLAYERS
          TABLE 15 SOLUTIONS: MARKET, BY TYPE,  2021–2028 (USD MILLION)
           7.2.1 PATIENT ACCESS SOLUTIONS
                    TABLE 16 PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 17 PATIENT ACCESS SOLUTIONS MARKET, BY COUNTRY/REGION,  2021–2028 (USD MILLION)
                    7.2.1.1 Eligibility verification solutions
                               7.2.1.1.1 Eligibility verification solutions segment to account for largest share of patient access solutions market
                                               TABLE 18 ELIGIBILITY VERIFICATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS
                                               TABLE 19 ELIGIBILITY VERIFICATION SOLUTIONS MARKET, BY COUNTRY/REGION,  2021–2028 (USD MILLION)
                    7.2.1.2 Pre-certification & authorization solutions
                               7.2.1.2.1 Electronic pre-certification and authorization help reduce error risks
                                               TABLE 20 PRE-CERTIFICATION & AUTHORIZATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS
                                               TABLE 21 PRE-CERTIFICATION & AUTHORIZATION SOLUTIONS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION)
                    7.2.1.3 Other patient access solutions
                                TABLE 22 OTHER PATIENT ACCESS SOLUTIONS OFFERED BY KEY MARKET PLAYERS
                                TABLE 23 OTHER PATIENT ACCESS SOLUTIONS MARKET, BY COUNTRY/REGION,  2021–2028 (USD MILLION)
           7.2.2 MID-REVENUE CYCLE SOLUTIONS
                    TABLE 24 MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 25 MID-REVENUE CYCLE SOLUTIONS MARKET, BY COUNTRY/REGION,  2021–2028 (USD MILLION)
                    7.2.2.1 Clinical coding solutions
                               7.2.2.1.1 Increasing complexity of medical codes to drive market
                                               TABLE 26 CLINICAL CODING SOLUTIONS OFFERED BY KEY MARKET PLAYERS
                                               TABLE 27 CLINICAL CODING SOLUTIONS MARKET, BY COUNTRY/REGION,  2021–2028 (USD MILLION)
                    7.2.2.2 Clinical documentation improvement solutions
                               7.2.2.2.1 Automated feedback and guidance by CDI solutions help physicians improve accuracy of patient records
                                               TABLE 28 CLINICAL DOCUMENTATION IMPROVEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS
                                               TABLE 29 CLINICAL DOCUMENTATION IMPROVEMENT SOLUTIONS MARKET, BY COUNTRY/ REGION, 2021–2028 (USD MILLION)
                    7.2.2.3 Other mid-revenue cycle solutions
             TABLE 30 OTHER MID-REVENUE CYCLE SOLUTIONS OFFERED BY KEY MARKET PLAYERS
             TABLE 31 OTHER MID-REVENUE CYCLE SOLUTIONS MARKET, BY COUNTRY/REGION,  2021–2028 (USD MILLION)
           7.2.3 BACK-END REVENUE CYCLE SOLUTIONS
                    TABLE 32 BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 33 BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY COUNTRY/REGION,  2021–2028 (USD MILLION)
                    7.2.3.1 Claims processing solutions
                               7.2.3.1.1 Claims processing solutions help reduce false claims and manual effort
                                               TABLE 34 CLAIMS PROCESSING SOLUTIONS OFFERED BY KEY MARKET PLAYERS
                                               TABLE 35 CLAIMS PROCESSING SOLUTIONS MARKET, BY COUNTRY/REGION,  2021–2028 (USD MILLION)
                    7.2.3.2 Denial management solutions
                               7.2.3.2.1 Denial management solutions help healthcare payers and providers with effective claims management
                                               TABLE 36 DENIAL MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS
                                               TABLE 37 DENIAL MANAGEMENT SOLUTIONS MARKET, BY COUNTRY/REGION,  2021–2028 (USD MILLION)
                    7.2.3.3 Other back-end revenue cycle solutions
                                TABLE 38 OTHER BACK-END REVENUE CYCLE SOLUTIONS OFFERED BY KEY MARKET PLAYERS
                                TABLE 39 OTHER BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY COUNTRY/REGION,  2021–2028 (USD MILLION)
    7.3 OUTSOURCING SERVICES 
          TABLE 40 OUTSOURCING SERVICES: MARKET, BY TYPE,  2021–2028 (USD MILLION)
          TABLE 41 OUTSOURCING SERVICES: MARKET,  BY COUNTRY/REGION, 2021–2028(USD MILLION)
           7.3.1 PATIENT ACCESS OUTSOURCING SERVICES
                    7.3.1.1 Patient access outsourcing services segment to account for largest share of outsourcing services market
                                TABLE 42 PATIENT ACCESS OUTSOURCING SERVICES OFFERED BY KEY MARKET PLAYERS
                                TABLE 43 PATIENT ACCESS OUTSOURCING SERVICES MARKET, BY COUNTRY/REGION,  2021–2028 (USD MILLION)
           7.3.2 MID-REVENUE CYCLE OUTSOURCING SERVICES
                    7.3.2.1 Increasing losses due to billing errors, scarcity of IT professionals, and infrastructure limitations to drive market
                                TABLE 44 MID-REVENUE CYCLE OUTSOURCING SERVICES OFFERED BY KEY MARKET PLAYERS
                                TABLE 45 MID-REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY COUNTRY/REGION,  2021–2028 (USD MILLION)
           7.3.3 BACK-END REVENUE CYCLE OUTSOURCING SERVICES
                    7.3.3.1 Shortage of skilled HCIT professionals to drive market
                                TABLE 46 BACK-END REVENUE CYCLE OUTSOURCING SERVICES OFFERED BY KEY MARKET PLAYERS
                                TABLE 47 BACK-END REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION)
 
8 REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE (Page No. - 118)
    8.1 INTRODUCTION 
          TABLE 48 REVENUE CYCLE MANAGEMENT INDUSTRY, BY DELIVERY MODE,  2021–2028 (USD MILLION)
    8.2 ON-PREMISES SOLUTIONS 
           8.2.1 ABILITY TO REUSE EXISTING SERVERS AND STORAGE HARDWARE TO DRIVE DEMAND FOR ON-PREMISES SOLUTIONS
                    TABLE 49 ON-PREMISES SOLUTIONS: MARKET,  BY COUNTRY/REGION, 2021–2028 (USD MILLION)
    8.3 CLOUD-BASED SOLUTIONS 
           8.3.1 DEMAND FOR AFFORDABLE CLOUD-BASED REVENUE CYCLE MANAGEMENT SOLUTIONS FROM SMALL AND MEDIUM-SIZED HEALTHCARE FACILITIES TO DRIVE MARKET
                    TABLE 50 CLOUD-BASED SOLUTIONS: MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION)
 
9 REVENUE CYCLE MANAGEMENT MARKET, BY END USER (Page No. - 122)
    9.1 INTRODUCTION 
          TABLE 51 REVENUE CYCLE MANAGEMENT INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    9.2 HEALTHCARE PROVIDERS 
          TABLE 52 MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,  2021–2028 (USD MILLION)
          TABLE 53 MARKET FOR HEALTHCARE PROVIDERS,  BY COUNTRY/REGION, 2021–2028 (USD MILLION)
           9.2.1 INPATIENT FACILITIES
                    TABLE 54 MARKET FOR INPATIENT FACILITIES, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 55 MARKET FOR INPATIENT FACILITIES,  BY COUNTRY/REGION, 2021–2028 (USD MILLION)
                    9.2.1.1 Hospitals
                               9.2.1.1.1 Growing need to improve profitability in healthcare operations to drive adoption of RCM tools in hospitals
                                              TABLE 56 MARKET FOR HOSPITALS, BY COUNTRY/REGION,  2021–2028 (USD MILLION)
                    9.2.1.2 Other inpatient facilities
                                TABLE 57 MARKET FOR OTHER INPATIENT FACILITIES,  BY COUNTRY/REGION, 2021–2028 (USD MILLION)
           9.2.2 OUTPATIENT FACILITIES
                    TABLE 58 MARKET FOR OUTPATIENT FACILITIES, BY TYPE,  2021–2028 (USD MILLION)
                    TABLE 59 MARKET FOR OUTPATIENT FACILITIES,  BY COUNTRY/REGION, 2021–2028 (USD MILLION)
                    9.2.2.1 Physician practices
                               9.2.2.1.1 High demand for integration of EHR with practice management systems among physician practices
                                              TABLE 60 MARKET FOR PHYSICIAN PRACTICES,  BY COUNTRY/REGION, 2021–2028 (USD MILLION)
                    9.2.2.2 Ambulatory surgical centers (ASCs)
                               9.2.2.2.1 Eroding patient volumes at hospitals due to high infection rate of COVID-19 to drive demand for ASCs
                                              TABLE 61 MARKET FOR AMBULATORY SURGICAL CENTERS,  BY COUNTRY/REGION, 2021–2028 (USD MILLION)
                    9.2.2.3 Hospital outpatient facilities
                               9.2.2.3.1 Need to maintain documentation for high volume of patients in hospital OPDs to drive demand for RCM solutions
                                              TABLE 62 MARKET FOR HOSPITAL OUTPATIENT FACILITIES,  BY COUNTRY/REGION, 2021–2028 (USD MILLION)
                    9.2.2.4 Diagnostic & imaging centers
                               9.2.2.4.1 Growing preference of patients for shorter waiting times & technologically advanced specialty clinics to drive demand for diagnostic & imaging centers
                                              TABLE 63 MARKET FOR DIAGNOSTIC & IMAGING CENTERS,  BY COUNTRY/REGION, 2021–2028 (USD MILLION)
                    9.2.2.5 Other outpatient facilities
                                TABLE 64 MARKET FOR OTHER OUTPATIENT FACILITIES,  BY COUNTRY/REGION, 2021–2028 (USD MILLION)
    9.3 HEALTHCARE PAYERS 
           9.3.1 INCREASING PRODUCTIVITY AND PROFITABILITY OF CODING OPERATIONS TO DRIVE ADOPTION OF RCM SOLUTIONS BY HEALTHCARE PAYERS
                    TABLE 65 MARKET FOR HEALTHCARE PAYERS,  BY COUNTRY/REGION, 2021–2028 (USD MILLION)
 
10 REVENUE CYCLE MANAGEMENT MARKET, BY REGION (Page No. - 136)
     10.1 INTRODUCTION 
             TABLE 66 REVENUE CYCLE MANAGEMENT INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
     10.2 NORTH AMERICA 
             FIGURE 26 NORTH AMERICA: MARKET SNAPSHOT
             TABLE 67 NORTH AMERICA: MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
             TABLE 68 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
             TABLE 69 NORTH AMERICA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 70 NORTH AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 71 NORTH AMERICA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 72 NORTH AMERICA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 73 NORTH AMERICA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 74 NORTH AMERICA: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
             TABLE 75 NORTH AMERICA: MARKET, BY END USER,  2021–2028 (USD MILLION)
             TABLE 76 NORTH AMERICA: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 77 NORTH AMERICA: MARKET FOR INPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
             TABLE 78 NORTH AMERICA: REVENUE CYCLE MANAGEMENT INDUSTRY FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Growing focus of healthcare providers on improving care quality and reducing medical errors & healthcare expenses to drive market
                                      TABLE 79 US: KEY MACRO INDICATORS
                                      TABLE 80 US: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 81 US: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 82 US: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 83 US: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 84 US: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 85 US: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 86 US: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
                                      TABLE 87 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 88 US: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 89 US: MARKET FOR INPATIENT FACILITIES, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 90 US: MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Need for healthcare cost containment and financial management of healthcare organizations to support market growth
                                      TABLE 91 CANADA: KEY MACRO INDICATORS
                                      TABLE 92 CANADA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 93 CANADA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 94 CANADA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 95 CANADA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 96 CANADA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 97 CANADA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 98 CANADA: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
                                      TABLE 99 CANADA: MARKET, BY END USER,  2021–2028 (USD MILLION)
                                      TABLE 100 CANADA: MARKET FOR HEALTHCARE PROVIDERS,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 101 CANADA: MARKET FOR INPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 102 CANADA: REVENUE CYCLE MANAGEMENT INDUSTRY FOR OUTPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
     10.3 EUROPE 
             TABLE 103 EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
             TABLE 104 EUROPE: MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
             TABLE 105 EUROPE: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 106 EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 107 EUROPE: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 108 EUROPE: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 109 EUROPE: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 110 EUROPE: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
             TABLE 111 EUROPE: MARKET, BY END USER,  2021–2028 (USD MILLION)
             TABLE 112 EUROPE: MARKET FOR HEALTHCARE PROVIDERS,  BY TYPE, 2021–2028 (USD MILLION)
             TABLE 113 EUROPE: MARKET FOR INPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
             TABLE 114 EUROPE: MARKET FOR OUTPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Increasing patient volume to boost adoption of RCM solutions
                                      TABLE 115 GERMANY: KEY MACRO INDICATORS
                                      TABLE 116 GERMANY: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 117 GERMANY: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 118 GERMANY: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 119 GERMANY: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 120 GERMANY: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 121 GERMANY: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 122 GERMANY: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
                                      TABLE 123 GERMANY: MARKET, BY END USER,  2021–2028 (USD MILLION)
                                      TABLE 124 GERMANY: MARKET FOR HEALTHCARE PROVIDERS,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 125 GERMANY: MARKET FOR INPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 126 GERMANY: REVENUE CYCLE MANAGEMENT INDUSTRY FOR OUTPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
             10.3.2 FRANCE
                        10.3.2.1 Government investments to increase demand for effective RCM solutions
                                      TABLE 127 FRANCE: KEY MACRO INDICATORS
                                      TABLE 128 FRANCE: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 129 FRANCE: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 130 FRANCE: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 131 FRANCE: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 132 FRANCE: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 133 FRANCE: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 134 FRANCE: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
                                      TABLE 135 FRANCE: MARKET, BY END USER,  2021–2028 (USD MILLION)
                                      TABLE 136 FRANCE: MARKET FOR HEALTHCARE PROVIDERS,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 137 FRANCE: MARKET FOR INPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 138 FRANCE: MARKET FOR OUTPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
             10.3.3 UK
                        10.3.3.1 Growing patient pool to boost demand for RCM solutions & services
                                      TABLE 139 UK: KEY MACRO INDICATORS
                                      TABLE 140 UK: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 141 UK: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 142 UK: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 143 UK: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 144 UK: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 145 UK: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 146 UK: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
                                      TABLE 147 UK: MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 148 UK: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 149 UK: MARKET FOR INPATIENT FACILITIES, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 150 UK: REVENUE CYCLE MANAGEMENT INDUSTRY FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Initiatives toward digitalizing patient records to drive market
                                      TABLE 151 ITALY: KEY MACRO INDICATORS
                                      TABLE 152 ITALY: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 153 ITALY: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 154 ITALY: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 155 ITALY: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 156 ITALY: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 157 ITALY: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 158 ITALY: MARKET, BY END USER,  2021–2028 (USD MILLION)
                                      TABLE 159 ITALY: MARKET FOR HEALTHCARE PROVIDERS,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 160 ITALY: MARKET FOR INPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 161 ITALY: MARKET FOR OUTPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 IT infrastructural improvements to boost market
                                      TABLE 162 SPAIN: KEY MACRO INDICATORS
                                      TABLE 163 SPAIN: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 164 SPAIN: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 165 SPAIN: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 166 SPAIN: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 167 SPAIN: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 168 SPAIN: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 169 SPAIN: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
                                      TABLE 170 SPAIN: MARKET, BY END USER,  2021–2028 (USD MILLION)
                                      TABLE 171 SPAIN: MARKET FOR HEALTHCARE PROVIDERS,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 172 SPAIN: MARKET FOR INPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 173 SPAIN: REVENUE CYCLE MANAGEMENT INDUSTRY FOR OUTPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 174 REST OF EUROPE: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 175 REST OF EUROPE: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 176 REST OF EUROPE: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 177 REST OF EUROPE: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 178 REST OF EUROPE: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 179 REST OF EUROPE: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 180 REST OF EUROPE: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
                        TABLE 181 REST OF EUROPE: MARKET, BY END USER,  2021–2028 (USD MILLION)
                        TABLE 182 REST OF EUROPE: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 183 REST OF EUROPE: MARKET FOR INPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 184 REST OF EUROPE: MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION)
     10.4 ASIA PACIFIC 
             FIGURE 27 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET SNAPSHOT
             TABLE 185 ASIA PACIFIC: MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
             TABLE 186 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
             TABLE 187 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 188 ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 189 ASIA PACIFIC: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 190 ASIA PACIFIC: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 191 ASIA PACIFIC: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
             TABLE 192 ASIA PACIFIC: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
             TABLE 193 ASIA PACIFIC: MARKET, BY END USER,  2021–2028 (USD MILLION)
             TABLE 194 ASIA PACIFIC: MARKET FOR HEALTHCARE PROVIDERS,  BY TYPE, 2021–2028 (USD MILLION)
             TABLE 195 ASIA PACIFIC: MARKET FOR INPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
             TABLE 196 ASIA PACIFIC: REVENUE CYCLE MANAGEMENT INDUSTRY FOR OUTPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Government mandates to boost adoption of RCM solutions
                                      TABLE 197 JAPAN: KEY MACRO INDICATORS
                                      TABLE 198 JAPAN: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 199 JAPAN: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 200 JAPAN: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 201 JAPAN: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 202 JAPAN: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 203 JAPAN: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 204 JAPAN: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
                                      TABLE 205 JAPAN: MARKET, BY END USER,  2021–2028 (USD MILLION)
                                      TABLE 206 JAPAN: MARKET FOR HEALTHCARE PROVIDERS,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 207 JAPAN: MARKET FOR INPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 208 JAPAN: MARKET FOR OUTPATIENT FACILITIES,  BY TYPE 2021–2028 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Digitalization and improving infrastructure to support market growth
                                      TABLE 209 CHINA: KEY MACRO INDICATORS
                                      TABLE 210 CHINA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 211 CHINA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 212 CHINA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 213 CHINA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 214 CHINA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 215 CHINA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 216 CHINA: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
                                      TABLE 217 CHINA: MARKET, BY END USER,  2021–2028 (USD MILLION)
                                      TABLE 218 CHINA: MARKET FOR HEALTHCARE PROVIDERS,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 219 CHINA: MARKET FOR INPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 220 CHINA: MARKET FOR OUTPATIENT FACILITIES,  BY TYPE 2021–2028 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Growing patient pool to support market growth
                                      TABLE 221 INDIA: KEY MACRO INDICATORS
                                      TABLE 222 INDIA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                      TABLE 223 INDIA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 224 INDIA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 225 INDIA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 226 INDIA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 227 INDIA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                                      TABLE 228 INDIA: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
                                      TABLE 229 INDIA: MARKET, BY END USER,  2021–2028 (USD MILLION)
                                      TABLE 230 INDIA: MARKET FOR HEALTHCARE PROVIDERS,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 231 INDIA: MARKET FOR INPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 232 INDIA: MARKET FOR OUTPATIENT FACILITIES, BY TYPE 2021–2028 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                        TABLE 233 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 234 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 235 REST OF ASIA PACIFIC: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 236 REST OF ASIA PACIFIC: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 237 REST OF ASIA PACIFIC: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 238 REST OF ASIA PACIFIC: REVENUE CYCLE OUTSOURCING SERVICES MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 239 REST OF ASIA PACIFIC: MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                        TABLE 240 REST OF ASIA PACIFIC: MARKET, BY END USER,  2021–2028 (USD MILLION)
                        TABLE 241 REST OF ASIA PACIFIC: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 242 REST OF ASIA PACIFIC: MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 243 REST OF ASIA PACIFIC: REVENUE CYCLE MANAGEMENT INDUSTRY FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION)
     10.5 LATIN AMERICA 
             10.5.1 HEALTHCARE INFRASTRUCTURAL DEVELOPMENTS TO SUPPORT MARKET GROWTH
                        TABLE 244 LATIN AMERICA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 245 LATIN AMERICA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 246 LATIN AMERICA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 247 LATIN AMERICA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 248 LATIN AMERICA: BACK-END REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 249 LATIN AMERICA: REVENUE CYCLE OUTSOURCING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 250 LATIN AMERICA: MARKET, BY DELIVERY MODE,  2021–2028 (USD MILLION)
                        TABLE 251 LATIN AMERICA: MARKET, BY END USER,  2021–2028 (USD MILLION)
                        TABLE 252 LATIN AMERICA: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 253 LATIN AMERICA: MARKET FOR INPATIENT FACILITIES,  BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 254 LATIN AMERICA: MARKET FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 GOVERNMENT FUNDING & INITIATIVES TO SUPPORT MARKET GROWTH
                        TABLE 255 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 256 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT SOLUTIONS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 257 MIDDLE EAST & AFRICA: PATIENT ACCESS SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 258 MIDDLE EAST & AFRICA: MID-REVENUE CYCLE SOLUTIONS MARKET, BY TYPE,  2021–2028 (USD MILLION)
                        TABLE 259 MIDDLE EAST & AFRICA: BACK-END REVENUE CYCLE SOLUTIONS MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 260 MIDDLE EAST & AFRICA: REVENUE CYCLE OUTSOURCING SERVICES MARKET,  BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 261 MIDDLE EAST & AFRICA: MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                        TABLE 262 MIDDLE EAST & AFRICA: MARKET, BY END USER,  2021–2028 (USD MILLION)
                        TABLE 263 MIDDLE EAST & AFRICA: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 264 MIDDLE EAST & AFRICA: MARKET FOR INPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 265 MIDDLE EAST & AFRICA: REVENUE CYCLE MANAGEMENT INDUSTRY FOR OUTPATIENT FACILITIES, BY TYPE, 2021–2028 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 234)
     11.1 OVERVIEW 
             FIGURE 28 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY  2020 AND JUNE 2023
     11.2 MARKET RANKING ANALYSIS 
             FIGURE 29 REVENUE CYCLE MANAGEMENT, BY PLAYER, 2022
     11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 30 REVENUE CYCLE MANAGEMENT: REVENUE ANALYSIS OF KEY PLAYERS
     11.4 REVENUE CYCLE MANAGEMENT MARKET: R&D EXPENDITURE 
             FIGURE 31 R&D EXPENDITURE OF KEY PLAYERS (2021 VS. 2022)
     11.5 COMPETITIVE BENCHMARKING 
             TABLE 266 COMPANY FOOTPRINT ANALYSIS
             TABLE 267 COMPANY PRODUCT AND SERVICES FOOTPRINT
             TABLE 268 COMPANY END USER FOOTPRINT
             TABLE 269 COMPANY REGIONAL FOOTPRINT
     11.6 COMPANY EVALUATION MATRIX 
             11.6.1 STARS
             11.6.2 EMERGING LEADERS
             11.6.3 PERVASIVE PLAYERS
             11.6.4 PARTICIPANTS
                        FIGURE 32 REVENUE CYCLE MANAGEMENT INDUSTRY: COMPANY EVALUATION  MATRIX (2022)
     11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 DYNAMIC COMPANIES
             11.7.3 RESPONSIVE COMPANIES
             11.7.4 STARTING BLOCKS
                        FIGURE 33 REVENUE CYCLE MANAGEMENT: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
     11.8 COMPETITIVE SCENARIO 
             11.8.1 PRODUCT LAUNCHES
                        TABLE 270 REVENUE CYCLE MANAGEMENT INDUSTRY: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023
             11.8.2 DEALS
                        TABLE 271 REVENUE CYCLE MANAGEMENT INDUSTRY: DEALS, JANUARY 2020–MAY 2023
 
12 COMPANY PROFILES (Page No. - 247)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     12.1 KEY PLAYERS 
             12.1.1 OPTUM, INC.
                        TABLE 272 OPTUM, INC.: BUSINESS OVERVIEW
                        FIGURE 34 OPTUM, INC.: COMPANY SNAPSHOT (2022)
             12.1.2 R1 RCM, INC.
                        TABLE 273 R1 RCM, INC.: BUSINESS OVERVIEW
             12.1.3 ORACLE
                        TABLE 274 ORACLE: BUSINESS OVERVIEW
                        FIGURE 35 ORACLE: COMPANY SNAPSHOT (2022)
             12.1.4 CHANGE HEALTHCARE
                        TABLE 275 CHANGE HEALTHCARE: BUSINESS OVERVIEW
                        FIGURE 36 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2022)
             12.1.5 MCKESSON CORPORATION
                        TABLE 276 MCKESSON CORPORATION: BUSINESS OVERVIEW
                        FIGURE 37 MCKESSON CORPORATION: COMPANY SNAPSHOT (2022)
             12.1.6 3M
                        TABLE 277 3M: BUSINESS OVERVIEW
                        FIGURE 38 3M: COMPANY SNAPSHOT (2022)
             12.1.7 EXPERIAN PLC
                        TABLE 278 EXPERIAN PLC: BUSINESS OVERVIEW
                        FIGURE 39 EXPERIAN PLC: COMPANY SNAPSHOT (2022)
             12.1.8 CONIFER HEALTH SOLUTIONS, LLC
                        TABLE 279 CONIFER HEALTH SOLUTIONS, LLC: BUSINESS OVERVIEW
                        FIGURE 40 CONIFER HEALTH SOLUTIONS, LLC: COMPANY SNAPSHOT (2022)
             12.1.9 VERADIGM LLC
                        TABLE 280 VERADIGM LLC: BUSINESS OVERVIEW
                        FIGURE 41 VERADIGM LLC: COMPANY SNAPSHOT (2021)
             12.1.10 GE HEALTHCARE
                        TABLE 281 GE HEALTHCARE: BUSINESS OVERVIEW
                        FIGURE 42 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
             12.1.11 COGNIZANT
                        TABLE 282 COGNIZANT: BUSINESS OVERVIEW
                        FIGURE 43 COGNIZANT: COMPANY SNAPSHOT (2022)
             12.1.12 ATHENAHEALTH, INC.
                        TABLE 283 ATHENAHEALTH: BUSINESS OVERVIEW
             12.1.13 THE SSI GROUP, LLC
                        TABLE 284 THE SSI GROUP, LLC: BUSINESS OVERVIEW
             12.1.14 ADVANTEDGE HEALTHCARE SOLUTIONS
                        TABLE 285 ADVANTEDGE HEALTHCARE SOLUTIONS: BUSINESS OVERVIEW
             12.1.15 HURON CONSULTING GROUP INC.
                        TABLE 286 HURON CONSULTING GROUP INC.: BUSINESS OVERVIEW
                        FIGURE 44 HURON CONSULTING GROUP INC.: COMPANY SNAPSHOT (2022)
             12.1.16 FINTHRIVE
                        TABLE 287 FINTHRIVE: BUSINESS OVERVIEW
             12.1.17 PLUTUS HEALTH
                        TABLE 288 PLUTUS HEALTH: BUSINESS OVERVIEW
             12.1.18 QUEST DIAGNOSTICS INCORPORATED
                        TABLE 289 QUEST DIAGNOSTICS INCORPORATED: BUSINESS OVERVIEW
                        FIGURE 45 QUEST DIAGNOSTICS INCORPORATED: COMPANY SNAPSHOT (2022)
             12.1.19 GEBBS
                        TABLE 290 GEBBS: BUSINESS OVERVIEW
             12.1.20 EPIC SYSTEMS CORPORATION
                        TABLE 291 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
     12.2 OTHER PLAYERS 
             12.2.1 OMEGA HEALTHCARE
             12.2.2 TRUBRIDGE
             12.2.3 CARECLOUD, INC.
             12.2.4 CONSTELLATION SOFTWARE INC.
             12.2.5 VEE TECHNOLOGIES
 
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 323)
     13.1 INSIGHTS FROM INDUSTRY EXPERTS 
     13.2 DISCUSSION GUIDE 
     13.3 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     13.4 CUSTOMIZATION OPTIONS 
     13.5 RELATED REPORTS 
     13.6 AUTHOR DETAILS 
 

This study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

Secondary Research

This research study involved the wide use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial revenue cycle management market study. It was also used to obtain important information about the key players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the revenue cycle management market. The primary sources from the demand side include clinicians, cardiologists, hospital managers, professors, and and stakeholders in corporate & government bodies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

A breakdown of the primary respondents is provided below:

Revenue Cycle Management Market Size, and Share

Tiers are defined based on a company’s total revenue. As of 2022: Tier 1= >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3= <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the revenue cycle management market was arrived at after data triangulation from four different approaches. After each course, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

Method for calculating the revenue of different players in revenue cycle management.  Annual reports, SEC filings, online publications, and in-depth primary interviews were used to determine the size of the worldwide revenue cycle management market. The market segment sizes were determined using a percentage split. In order to determine the size for each sub-segment, additional splits were used. Primary participants verified these percentage splits. The country-level market numbers from yearly reports, SEC filings, online publications, and in-depth primary interviews were summed up to determine the total market size for regions. The global revenue cycle management market was calculated by adding the market sizes for each region.

Approach to derive the market size and estimate market growth

The market size and market growth were estimated through primary interviews on a regional and global level. All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Global revenue cycle management market size: Top-Down Approach

Revenue Cycle Management Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

The market was divided into a number of segments and sub-segments after the overall market size was estimated through the above-described market size estimation processes. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Revenue cycle management (RCM) is the process used to track the revenue from patients, from their initial appointment or encounter with the healthcare system to their final payment of the balance. This process helps streamline the business operations of healthcare organizations and private practices. RCM solutions help providers manage and enhance revenue cycle functions such as medical coding & billing, patient insurance eligibility verification, electronic health records, clinical documentation, and claims & denials management.

Key Stakeholders

  • Healthcare Providers
  • Healthcare Vendors
  • Technology Developers
  • Patients
  • Regulators and Policy makers
  • Insurance companies and payers
  • Government Institutions
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors

Objectives of the Study

  • To define, describe, and forecast the global revenue cycle management market by product & services, delivery mode, end-user, and region
  • To provide detailed information about the significant factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall revenue cycle management market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the revenue cycle management market in five major regions along with their respective key countries (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)
  • To profile the key players in the global revenue cycle management market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as mergers, acquisitions, developments, expansions, partnerships, alliances, and R&D activities of leading players in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of the Asia Pacific market into South Korea, Australia, New Zealand, and others
  • Further breakdown of the Rest of Europe market into Belgium, Russia, Switzerland, and others
  • Further breakdown of the Rest of the Latin America market into Brazil, Argentina, Colombia, Chile, and others
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
HIT 4017
Published ON
Jun, 2023
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Revenue Cycle Management Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback